Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Sun Pharmaceuticals Industries Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn

Sun Pharmaceuticals Industries Ltd: Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 10.5% to ₹15,300 crore against Jun 2025. Net profit rose 26.5% to ₹2,901 crore against the same period a year earlier. Operating margin fell from 31.1% to 28.9% (2.2 percentage points lower). Borrowings were ₹4,627 crore in Mar 2026, 95.9% above the prior-year balance.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 14 October 2026, 7:30 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price1,746₹ per share
Reported P/E33.2Times
Book value per share348₹ per share
Reported ROCE20.5 %Reported return

Stored market and accounting figures

Price record: 14 October 2026, 7:30 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap4,19,399 Cr.
Current Price1,746
High / Low2,048/1,584
Stock P/E33.2
Book Value348
Dividend Yield0.92 %
ROCE20.5 %
ROE16.0 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 10.5% to ₹15,300 crore against Jun 2025. Net profit rose 26.5% to ₹2,901 crore against the same period a year earlier. Operating margin fell from 31.1% to 28.9% (2.2 percentage points lower). Less operating profit was retained from each rupee of sales; compare the expense rows before attributing the change to a cause.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 11,94112,19212,38111,98312,65313,29113,67512,95913,85114,47815,52114,61215,300
Expenses 8,6099,0138,9048,9489,0459,3529,6669,2439,5509,95110,57210,65810,882
Operating Profit 3,3323,1793,4773,0353,6083,9394,0093,7164,3024,5274,9483,9544,418
OPM % 28%26%28%25%29%30%29%29%31%31%32%27%29%
Other Income -118294180504533354149251-35447089458520
Interest 8149357462695249751007886100
Depreciation 651633622650655626631664701730732775739
Profit before tax 2,4812,7913,0002,8163,4243,5983,4763,2543,1734,1684,2273,5514,099
Tax % 19%14%14%5%16%16%16%34%27%25%20%23%29%
Net Profit 2,0062,3852,5612,6592,8613,0372,9132,1542,2933,1253,3812,7102,901
EPS in Rs 8.439.9010.5211.0611.8212.6712.108.969.5013.0014.0411.3112.06

Last Updated: September 29, 2026, 5:26 pm

EARNINGS

Annual performance

Mar 2026

Sales expanded faster than earnings in the year ending Mar 2026. Sales rose 11.2% to ₹58,462 crore against Mar 2025. Net profit rose 5.0% to ₹11,509 crore against the same period a year earlier. Operating margin fell from 28.7% to 28.2% (0.5 percentage points lower). Less operating profit was retained from each rupee of sales; compare the expense rows before attributing the change to a cause.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 4:37 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 27,39228,48731,57826,48929,06632,83833,49838,65443,88648,49752,57858,46259,911
Expenses 19,49820,31321,47620,85822,68925,85525,02828,39732,23535,47937,46441,96142,063
Operating Profit 7,8948,17410,1025,6316,3776,9838,47010,25811,65013,01815,11416,50117,847
OPM % 29%29%32%21%22%21%25%27%27%27%29%28%30%
Other Income 283-42610-135-258382-3,449-3,5054598651,4441,8951,537
Interest 579523400518555303141127172238231339364
Depreciation 1,1951,0381,2651,5001,7532,0532,0802,1442,5292,5572,5752,9382,976
Profit before tax 6,4036,5719,0483,4793,8105,0102,7994,4819,40811,08813,75215,11916,045
Tax % 14%14%13%26%16%16%18%24%9%13%20%24%
Net Profit 5,4765,6587,8462,5423,2084,1722,2723,3898,5139,61010,96511,50912,117
EPS in Rs 21.9218.8929.038.7311.1115.6912.1013.6435.3239.9145.5547.8450.41
Dividend Payout % 14%5%12%23%25%25%62%73%33%34%35%33%
Year-on-year profit growth table

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)3.32%38.67%-67.60%26.20%30.05%-45.54%49.16%151.20%12.89%14.10%4.96%
Change in YoY Net Profit Growth (%)0.00%35.35%-106.27%93.80%3.85%-75.59%94.71%102.03%-138.31%1.21%-9.14%

Growth

Compounded Sales Growth
10 Years:7%
5 Years:10%
3 Years:11%
TTM:9%
Compounded Profit Growth
10 Years:10%
5 Years:24%
3 Years:20%
TTM:9%
Stock Price CAGR
10 Years:6%
5 Years:25%
3 Years:21%
1 Year:-13%
Return on Equity
10 Years:14%
5 Years:16%
3 Years:17%
Last Year:17%

Last Updated: September 5, 2025, 1:36 pm

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹4,627 crore in Mar 2026. They increased from ₹2,362 crore in Mar 2025 (95.9% higher). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: July 22, 2026, 5:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 207241240240240240240240240240240240
Reserves 25,43132,74236,40038,07441,16945,02546,22347,77155,75563,42771,97883,330
Borrowings 8,9968,4979,83210,38510,5148,3153,8691,2906,8863,2742,3624,627
Other Liabilities 14,08913,94814,62415,59812,66614,61517,29120,47417,83118,38717,32820,210
Total Liabilities 48,72355,42861,09564,29764,59068,19467,62269,77680,71285,32891,908108,407
Fixed Assets 12,68215,87217,67518,85321,83722,84721,55322,66524,06523,24822,58632,822
CWIP 2,0392,1752,8012,4651,4111,2201,5671,2874,9735,3546,6443,052
Investments 2,7161,8301,1927,1437,90310,1439,61212,84914,82415,02618,35424,723
Other Assets 31,28635,55039,42735,83733,43933,98434,89032,97536,84941,70044,32447,811
Total Assets 48,72355,42861,09564,29764,59068,19467,62269,77680,71285,32891,908108,407
CASH & FUNDING

Cash generation

Mar 2026

Operating activities generated ₹12,419 crore in Mar 2026. Reported free cash flow for the same period was ₹8,906 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business. Operating cash flow was equivalent to 107.9% of the ₹11,509 crore reported annual profit for the same year ending Mar 2026, before capital expenditure.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 5,6166,6867,0823,9072,1966,5556,1708,9854,95912,13514,07212,419
Cash from Investing Activity + -1,502-3,949-4,186-3,104-310-2,225407-5,556-7,220-763-5,183-10,405
Cash from Financing Activity + -1,187-1,889-2,285-1,539-2,731-5,715-5,980-5,1932,376-6,710-7,906-2,513
Net Cash Flow 2,927848611-736-844-1,386596-1,7651154,662983-498
Free Cash Flow 3,3163,3533,4922,013-9665,1055,0977,5502,8959,96412,0058,906
CFO/OP 93%106%90%83%48%113%85%78%56%105%96%89%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow3,316.003,353.003,492.002,013.00-966.005,105.005,097.007,550.002,895.009,964.0012,005.008,906.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 65 in Mar 2025. That is 10 days higher than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
CAPITAL RETURNS

Returns on capital & equity

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Returns on capital & equity

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 506887831081121059999958591
Inventory Days 410307370307338366311378315360338348
Days Payable 174178207197234192142167158194194210
Cash Conversion Cycle 286197251193212285274310255261229228
Working Capital Days 71-737-4-3131515147405565
ROCE %34%23%18%20%10%10%10%13%17%16%17%20%
SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 54.48% in Jun 2026. Their share was unchanged from Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. FIIs held 14.54% in Jun 2026, 2.72 percentage points below their holding in Jun 2025. DIIs held 22.06% in Jun 2026, 2.68 percentage points above their holding in Jun 2025.

Shareholding comparison

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
SHAREHOLDER PARTICIPATION

Shareholder count

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 54.48%54.48%54.48%54.48%54.48%54.48%54.48%54.48%54.48%54.48%54.48%54.48%
FIIs 16.78%17.08%17.72%17.23%18.01%18.04%17.96%17.26%16.55%16.12%15.94%14.54%
DIIs 19.56%19.42%18.71%19.17%18.48%18.43%18.58%19.38%20.12%20.72%21.00%22.06%
Government 0.10%0.11%0.11%0.11%0.11%0.11%0.11%0.11%0.11%0.11%0.11%0.11%
Public 9.05%8.92%8.97%9.00%8.89%8.92%8.86%8.76%8.72%8.57%8.48%8.81%
No. of Shareholders 6,16,5886,12,6266,31,3926,73,2176,57,3176,89,6237,04,9837,23,7707,43,8777,10,9006,90,9577,10,246
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Value Fund 15,472,731 4.7 2797.9315,466,0982026-06-11 16:24:440.04%
ICICI Prudential Equity & Debt Fund 12,064,048 4.33 2181.5412,144,2232026-06-11 16:24:44-0.66%
ICICI Prudential Large Cap Fund 11,249,940 2.69 2034.3311,153,5712026-06-11 16:24:440.86%
ICICI Prudential India Opportunities Fund 6,827,584 3.42 1234.637,527,5842026-03-24 00:22:07-9.3%
Nippon India Pharma Fund 6,406,349 13.85 1158.466,256,3492026-06-11 06:53:112.4%
Nippon India Large Cap Fund 6,084,880 2.13 1100.33N/AN/AN/A
ICICI Prudential Multi Asset Fund 5,581,574 1.21 1009.325,931,5742026-06-11 11:28:07-5.9%
ICICI Prudential Equity Savings Fund 5,507,179 5.9 995.86N/AN/AN/A
ICICI Prudential ELSS Tax Saver Fund 4,512,053 5.87 815.915,292,2232026-06-11 16:24:44-14.74%
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 4,338,091 11.76 784.464,389,4732026-06-11 16:24:44-1.17%
ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

%

Profitability ratios

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Distributions & retention

%

Distributions & retention

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 45.6039.9035.3013.6012.10
Diluted EPS (Rs.) 45.6039.9035.3013.6012.10
Cash EPS (Rs.) 56.5050.8746.2223.1318.19
Book Value[Excl.RevalReserv]/Share (Rs.) 301.00265.36247.22212.84206.23
Book Value[Incl.RevalReserv]/Share (Rs.) 301.00265.36247.22212.84206.23
Revenue From Operations / Share (Rs.) 219.14202.13182.91161.11139.62
PBDIT / Share (Rs.) 71.8459.9251.1947.1838.87
PBIT / Share (Rs.) 61.1149.2740.6438.2430.20
PBT / Share (Rs.) 57.3246.2139.2118.6811.67
Net Profit / Share (Rs.) 45.7640.2135.6814.209.52
NP After MI And SOA / Share (Rs.) 45.5539.9135.3213.6412.10
PBDIT Margin (%) 32.7829.6427.9829.2827.84
PBIT Margin (%) 27.8824.3722.2223.7321.63
PBT Margin (%) 26.1522.8621.4311.598.35
Net Profit Margin (%) 20.8819.8919.508.816.82
NP After MI And SOA Margin (%) 20.7819.7419.308.468.66
Return on Networth / Equity (%) 15.1315.0415.136.816.24
Return on Capital Employeed (%) 19.8317.2616.0217.4414.06
Return On Assets (%) 11.8611.2010.494.684.29
Long Term Debt / Equity (X) 0.000.000.000.000.01
Total Debt / Equity (X) 0.020.040.110.010.07
Asset Turnover Ratio (%) 0.590.580.580.560.49
Current Ratio (X) 2.892.562.002.041.89
Quick Ratio (X) 2.331.981.481.511.33
Inventory Turnover Ratio (X) 5.234.760.790.780.72
Dividend Payout Ratio (NP) (%) 33.0630.2629.7365.9653.68
Dividend Payout Ratio (CP) (%) 26.7623.8822.8939.8531.28
Earning Retention Ratio (%) 66.9469.7470.2734.0446.32
Cash Earning Retention Ratio (%) 73.2476.1277.1160.1568.72
Interest Coverage Ratio (X) 74.5060.2971.4088.8865.95
Interest Coverage Ratio (Post Tax) (X) 51.3943.5351.7763.6047.60
Enterprise Value (Cr.) 407192.46384570.80239622.86218440.19143296.74
EV / Net Operating Revenue (X) 7.747.935.465.654.28
EV / EBITDA (X) 23.6226.7519.5119.3015.36
MarketCap / Net Operating Revenue (X) 7.928.025.375.684.28
Retention Ratios (%) 66.9369.7370.2634.0346.31
Price / BV (X) 5.776.114.214.573.09
Price / Net Operating Revenue (X) 7.928.025.375.684.28
EarningsYield 0.020.020.030.010.02

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Sun Pharmaceuticals Industries Ltd 4,19,399 Cr. 1,746 2,048/1,58433.2 3480.92 %20.5 %16.0 % 1.00
Torrent Pharmaceuticals Ltd 1,74,505 Cr. 4,580 5,250/3,48378.2 2480.83 %15.2 %27.4 % 5.00
Laurus Labs Ltd 1,10,502 Cr. 2,037 2,071/870127 97.30.10 %16.0 %15.2 % 2.00
Cipla Ltd 1,06,029 Cr. 1,313 1,673/1,16629.6 4260.99 %15.5 %11.6 % 2.00
Dr Reddys Laboratories Ltd 1,01,367 Cr. 1,214 1,415/1,08031.5 4540.66 %13.0 %11.2 % 1.00
Industry Average17,076.32 Cr1,211.6152.97211.250.40%26.15%16.59%6.06

All Competitor Stocks of Sun Pharmaceuticals Industries Ltd

Explore Industry-wise Company financial data